You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Science in Mind

Geneticist critiques DNA patent argument

Late last year, the nation’s highest court said it would consider a legal challenge to patents that biotechnology company Myriad Genetics holds on genes linked to risk of breast cancer. Now, Eric Lander — a leader in the human genome project, a scientific adviser to President Obama, and the head of the Broad Institute in Cambridge — has weighed in.

In an amicus brief carefully described as Lander’s personal view, he argues that Utah-based Myriad has patented products of nature, which are ineligible for such protection.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week